
Deliberate AI is transforming mental health care through multimodal AI technologies that enhance diagnostics, monitoring, and treatment personalization. Their innovative products, including the digital health assistant Sophia™ and AI Notes, streamline clinical workflows and improve patient outcomes. With a strong foundation in academic research and a commitment to precision therapy, Deliberate AI is positioned to lead in the mental health sector, addressing the complexities of mental health challenges with advanced, data-driven solutions.

Deliberate AI is transforming mental health care through multimodal AI technologies that enhance diagnostics, monitoring, and treatment personalization. Their innovative products, including the digital health assistant Sophia™ and AI Notes, streamline clinical workflows and improve patient outcomes. With a strong foundation in academic research and a commitment to precision therapy, Deliberate AI is positioned to lead in the mental health sector, addressing the complexities of mental health challenges with advanced, data-driven solutions.
What they do: Ambient multimodal AI products for mental health (clinical tools and biomarker platform)
HQ: New York, New York, United States
Founded: 2020
Employees: 6
Total funding: USD 20,000,000
Mental health diagnostics, monitoring, and treatment personalization; CNS biomarker discovery.
2020
Biotechnology
Latest documented funding event was a grant on 2024-09-12; Crunchbase records multiple grant and seed events across six rounds.
“DARPA; National Institute of Mental Health; StartX (Stanford-StartX Fund); PharmStars; Taavet+Sten; Ulu Ventures; Diverse Angels; Head and Heart Capital; Mount Sinai Health System”